India must stop 'irrational' TB treatments: MSF

March 23, 2014 by Penelope Macrae

India must stop its doctors prescribing "irrational" treatments to cure tuberculosis, medical humanitarian group Medecins Sans Frontieres said Saturday, warning the practice is increasing drug-resistant strains of the disease.

India is already home to the highest number of tuberculosis (TB) sufferers globally with two million cases every year and drug-resistant strains are on the rise, Medecins Sans Frontieres or MSF said in a statement ahead of World TB day on Monday.

TB patients in India face a potentially "grave risk of developing drug-resistant TB due to irrational prescribing practices", MSF said.

While huge strides have been made in controlling TB worldwide, the emergence of deadly strains that cannot be cured with existing medicines has turned the illness into one of the globe's most urgent health concerns.

India's government has already said it seeking to tackle deepening TB drug resistance with a wide-ranging national diagnostic and treatment programme for the communicable, airborne disease that usually attacks the lungs.

But MSF urged health authorities to go farther and implement a "standardised first-line daily tuberculosis treatment regimen" in the public and private health sectors.

With public health care services overstretched, many TB patients turn to private doctors who have "never been trained to use TB drugs in a proper way", Leena Menghaney, India coordinator of MSF's Access Campaign, told AFP.

MSF said some prescriptions are "completely inappropriate".

"When the patients get to us, they have become resistant to the drugs and it becomes far harder to treat them," Menghaney said.

India, whose vast pharmaceutical industry churns out an ever-growing supply of copycat medicines to combat life-threatening diseases, has the largest private TB drug market.

There is "rampant proliferation" of TB drugs in a wide variety of dosages and combinations, and the emergence of drug-resistant strains in the country of 1.2 billion people is increasingly being linked to poor regulation, MSF said.

India's drug regulation is already under heavy fire from US authorities over another issue—worries about the quality of the country's medicines following a string of recalls.

Other countries have already taken steps to curb drug-resistant TB by ensuring drug regulators strictly regulate TB drugs in the private market, Menghaney said.

"Governments like Brazil have even taken the additional step of making the public sector the primary distributor of all TB drugs," Menghaney added.

TB is still the world's second most deadly infectious diseases among adults, after HIV/AIDS, and every year kills 1.3 million people and causes nearly nine million to fall ill, according to UN figures.

While TB is curable, one third of those who have it—some three million people—do not get the treatment they need, often because they are poor.

The World Health Organization estimates India has 64,000 patients with drug-resistant TB.

"India can ill afford to delay" reforms in policies to treat TB, said Menghaney, calling the number of drug-resistant TB cases in the country "alarming".

Some doctors have warned drug-resistant TB could spin out of control. Before modern treatments were developed in the 1940s, TB killed two-thirds of sufferers.

Explore further: Drug-resistant TB blamed on Indian treatment flaws

Related Stories

Drug-resistant TB blamed on Indian treatment flaws

March 23, 2012
(AP) -- India's inadequate government-run tuberculosis treatment programs and a lack of regulation of the sale of drugs that fight it are responsible for the spiraling number of drug-resistant cases that are difficult to ...

Tuberculosis in US hits record low, CDC reports

March 20, 2014
(HealthDay)—Rates of tuberculosis in the United States are falling, with cases at a historic low, health officials reported Thursday.

Promising class of antibiotics discovered for treatment of drug-resistant tuberculosis

March 5, 2014
St. Jude Children's Research Hospital scientists have discovered a promising new class of antibiotics that could aid efforts to overcome drug-resistance in tuberculosis (TB), a global killer. The drugs increased survival ...

Myanmar receives high-tech TB detection machines

September 10, 2013
Myanmar on Tuesday received four state-of-the-art machines to detect drug-resistant tuberculosis, one of its major health problems.

Myanmar must act fast to curb drug resistant TB, experts say

August 22, 2013
Health officials called Thursday for urgent action to tackle "alarming" rates of drug-resistant tuberculosis in Myanmar where nearly 9,000 people catch the strain of the infectious disease each year.

Probe highlights risk from South Africa's drug-resistant TB

January 17, 2014
A long-term probe has found that South Africans with highly drug-resistant TB are "systematically" discharged from hospital without being cured, placing themselves and others at risk, its authors said Friday.

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.